Create Free Account

By creating account you will get access to hot stocks & personalised emails

PhosCo Ltd

Basic Materials AU PHO

0.065AUD
-(-%)

Last update at 2024-12-24T00:15:00Z

Day Range

0.060.07
LowHigh

52 Week Range

0.020.09
LowHigh

Fundamentals

  • Previous Close 0.07
  • Market Cap18.45M
  • Volume109727
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-1.52557M
  • Revenue TTM0.04M
  • Revenue Per Share TTM-
  • Gross Profit TTM 0.00000M
  • Diluted EPS TTM-0.01

Analyst Recommendations

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2024-06-30 2023-06-30 2022-06-30 2021-06-30 2020-06-30
Type yearly yearly yearly yearly yearly
Date 2024-06-30 2023-06-30 2022-06-30 2021-06-30 2020-06-30
Income before tax -1.97724M -8.77163M -1.29513M -1.13230M -1.80894M
Minority interest - 2.41M - - -
Net income -1.73490M -6.36647M -1.29558M -1.13230M -1.80894M
Selling general administrative 0.97M 2.23M 0.68M 0.79M 1.36M
Selling and marketing expenses 0.56M 1.10M - 0.00001M -
Gross profit -0.01233M -0.00861M -0.00950M -0.18436M -0.45782M
Reconciled depreciation - 0.00861M 0.00950M - -
Ebit -1.53791M -8.47480M -1.66682M -1.14305M -1.84271M
Ebitda -1.52557M -8.46620M -1.65732M -1.14305M -1.84271M
Depreciation and amortization 0.01M 0.00861M 0.00950M 0.00113M 0.00181M
Non operating income net other - - - - -
Operating income -1.52557M -3.33434M -1.66682M -1.14305M -1.84271M
Other operating expenses 1.53M 3.33M 1.67M 1.14M 1.84M
Interest expense - 0.30M 0.24M 0.00000M 0.00000M
Tax provision - 0.00052M 0.00045M 0.00000M 0.00000M
Interest income - 0.32M 0.37M 0.00112M 0.00171M
Net interest income - -0.25921M -0.23853M 0.00112M 0.00171M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense -0.25467M 0.00052M 0.00045M -0.00225M -0.00352M
Total revenue - 0.04M 0.00019M 0.00112M 0.00171M
Total operating expenses 1.53M 3.33M 1.67M 1.14M 1.84M
Cost of revenue 0.01M 0.00861M 0.00950M 0.19M 0.46M
Total other income expense net -0.45166M -5.44590M 0.36M 0.00962M 0.03M
Discontinued operations - - - - -
Net income from continuing ops - -8.77215M -1.29558M -1.13230M -1.80894M
Net income applicable to common shares - -6.36647M -1.21951M -1.13230M -1.80894M
Preferred stock and other adjustments - - - - -
Breakdown 2024-06-30 2023-06-30 2022-06-30 2021-06-30 2020-06-30
Type yearly yearly yearly yearly yearly
Date 2024-06-30 2023-06-30 2022-06-30 2021-06-30 2020-06-30
Total assets 0.78M 1.43M 6.19M 0.67M 1.67M
Intangible assets - - - - -
Earning assets - - - - -
Other current assets 0.18M 0.20M 0.18M 0.02M 0.04M
Total liab 9.45M 2.27M 7.55M 0.62M 0.59M
Total stockholder equity -2.36957M -0.83987M 2.22M 0.05M 1.09M
Deferred long term liab - - - - -
Other current liab 0.58M 0.73M 0.85M 0.52M 0.49M
Common stock 60.33M 59.93M 56.80M 53.51M 53.42M
Capital stock - 59.93M 56.80M 53.51M 53.42M
Retained earnings -62.52260M -61.03458M -54.98788M -53.79857M -52.77233M
Other liab - - - - -
Good will - - - - -
Other assets - - - - -
Cash 0.55M 1.19M 1.81M 0.58M 1.56M
Cash and equivalents - 1.19M 1.81M 0.58M 1.56M
Total current liabilities 9.45M 8.22M 7.55M 0.62M 0.59M
Current deferred revenue 0.21M - - - -
Net debt 7.06M 4.97M 3.72M -0.57502M -1.56194M
Short term debt 7.60M 6.16M 5.53M 0.00000M 0.00000M
Short long term debt - 6.16M 5.53M - -
Short long term debt total 7.60M - 5.53M - -
Other stockholder equity -0.00000M 0.27M 0.41M 0.34M 0.44M
Property plant equipment - 0.02M 4.05M 0.04M 0.04M
Total current assets 0.72M 1.40M 2.13M 0.64M 1.64M
Long term investments - - - - -
Net tangible assets - -0.83987M 2.22M 0.05M 1.09M
Short term investments - - - - -
Net receivables 0.03M 0.02M 0.15M 0.01M 0.02M
Long term debt - - - - -
Inventory -0.02874M - - 0.03M 0.02M
Accounts payable 1.06M 1.09M 1.18M 0.10M 0.10M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income -0.17869M - 0.41M 0.34M 0.44M
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - - - - -
Deferred long term asset charges - - - - -
Non current assets total 0.06M 0.02M 4.05M 0.04M 0.04M
Capital lease obligations - - - - -
Long term debt total - 0.00000M 0.00000M 0.00000M 0.00000M
Breakdown 2024-06-30 2023-06-30 2022-06-30 2021-06-30 2020-06-30
Type yearly yearly yearly yearly yearly
Date 2024-06-30 2023-06-30 2022-06-30 2021-06-30 2020-06-30
Investments - -0.00702M -0.43995M - -0.02007M
Change to liabilities - 0.16M 0.11M -0.02626M -0.12367M
Total cashflows from investing activities - -0.00702M -0.43995M -0.43995M -0.02007M
Net borrowings - - - - -
Total cash from financing activities 0.90M 2.89M 3.26M 3.26M 2.10M
Change to operating activities - 0.11M 0.07M 0.00309M -0.00892M
Net income -1.73490M -6.36647M -1.21951M -1.13230M -1.80894M
Change in cash -0.63955M -0.62134M 1.22M -0.98692M 0.78M
Begin period cash flow 1.19M 1.81M 0.58M 1.56M 0.78M
End period cash flow 0.55M 1.19M 1.79M 0.58M 1.56M
Total cash from operating activities -1.48885M -3.46933M -1.56221M -0.98388M -1.29560M
Issuance of capital stock - 2.90M 3.43M - 2.10M
Depreciation 0.01M 0.00861M 0.00950M 0.00950M 0.00950M
Other cashflows from investing activities - - - - -
Dividends paid - - - - -
Change to inventory - - - - -
Change to account receivables 0.00909M 0.09M -0.08583M -0.01598M 0.00528M
Sale purchase of stock -0.09650M -0.01822M -0.16861M 0.00000M 2.10M
Other cashflows from financing activities 0.09M -0.00702M -0.43995M -0.16861M -0.02007M
Change to netincome - -1.98152M -0.44576M 0.19M 0.64M
Capital expenditures 0.05M 0.00702M 0.44M 0.44M 0.02M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 0.12M 0.36M 0.09M -0.13598M -0.12731M
Stock based compensation 0.02M 0.09M - 0.28M 0.64M
Other non cash items 0.09M 2.29M -0.44576M 0.28M 0.64M
Free cash flow -1.54302M -3.47636M -2.00216M -0.98388M -1.31567M

Peer Comparison

Sector: Basic Materials Industry: Other Industrial Metals & Mining

Company Change (AUD) Price (AUD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
PHO
PhosCo Ltd		 - -% 0.07 - - 461.14 20.97 - -3.2712
BHP
BHP Group Limited		 - -% 39.73 15.96 10.66 3.60 2.90 2.41 5.69
RIO
Rio Tinto Ltd		 - -% 116.16 11.02 14.18 3.48 2.13 2.26 5.49
FMG
Fortescue Ltd		 - -% 18.40 6.24 10.05 3.11 1.81 1.98 3.41
S32
South32 Ltd		 - -% 3.41 - 29.59 2.75 1.07 1.88 73.20

Reports Covered

Stock Research & News

View All

Profile

PhosCo Ltd, together with its subsidiaries, engages in the exploration and development of resource projects in North Africa. It explores for zinc, gold, base and precious metals, and lead deposits. The company holds 100% interest in the Zeflana project that consists of three permits covering a total area of approximately 78 square kilometers located in Tunisia; and the Sekarna Phosphate Project located northeast of Chaketma; Amoud project in the Northern Basin. It also holds a portfolio of exploration permits and applications in Northern and Central Tunisia. The company was formerly known as Celamin Holdings Limited and changed its name to PhosCo Ltd in January 2022. PhosCo Ltd was incorporated in 2009 and is based in South Melbourne, Australia.

PhosCo Ltd

96-100 Albert Road, South Melbourne, VIC, Australia, 3205

Key Executives

Name Title Year Born
Mr. Simon Peter Eley B.A., L.L.B. MD, CEO & Exec. Director 1973
Mr. Craig K. Smyth BCA (Acctg), C.A., CA, L.L.B., M App Fin CFO & Director 1973
Mr. Tarecq Elias Aldaoud BPHARM Exec. Director NA
Mr. Stefan Ross Company Sec. NA
Mr. Russell Luxford Technical Advisor NA
Mr. Simon Peter Eley B.A., L.L.B. MD, CEO & Executive Director 1973
Mr. Tarecq Elias Aldaoud BPHARM Executive Director NA
Mr. Stefan Ross Company Secretary NA
Mr. Simon Peter Eley B.A., L.L.B. MD, CEO & Executive Director 1973
Mr. Tarecq Elias Aldaoud BPHARM Executive Director NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.

Our Company

Useful Links

Contact Us

ISO Certified Market Research

Kalkine Solutions Private Limited, authorized representative of Kalkine Pty Ltd, holds ISO 27001:2022 certification bearing Certificate No.- IC-IS-2404072

Our Company

Useful Links

Contact Us

Disclaimer

The information given by Kalkine Pty Ltd ABN34 154 808 312 (Australian Financial Services License Number 425376) on this website is general information or advice only.

It does not take into account any of your personal objectives, circumstances or needs. Choosing an investment is an important decision. If you do not feel confident making a decision based on the recommendations Kalkine has made in our reports, you should consider obtaining personal advice from an authorised adviser.

There may be a product disclosure statement or other offer document for the securities and financial products we write about in Kalkine Reports. You should obtain a copy of the product disclosure statement or offer document before making any decision about whether to acquire the security or product. Terms & Conditions have been provided for our services, please go through them and also read our Financial Services Guide.

Our website may contain information on past performance of particular investments. Past performance is not an indicator of future performance. Hypothetical returns may not reflect actual performance. Any displays of potential investment opportunities are for sample purposes only and may not actually be available to investors.

The information on the website does not constitute an offer to sell securities or a solicitation of an offer to buy securities. Our reports contain general recommendations to invest in securities.

Copyright 2024 Krish Capital Pty. Ltd. All rights reserved. No part of this website, or its content, may be reproduced in any form without our prior consent.